Now Available
Acute Coronary Syndrome Self-Assessment Program (ACS-SAP™) is a comprehensive update on the diagnosis and management of patients with acute coronary syndrome.
There are no fees for participating in this CME activity. To receive credit during the period August 1, 2010 to July 31, 2012, participants must read the learning objectives and disclosure statements, and study and complete the educational activity in its entirety.
Target Audience
Cardiologists, Primary Care Internists, General Internists, and Family Practitioners
Learning Objectives
After completing this activity (ACS-SAP™), participants will be better able to:
- Identify signs, symptoms, and prognostic features of acute coronary syndrome and related ischemic conditions, and their implications for invasive vascular management.
- Describe the role of platelets in thrombosis and the development of acute coronary syndromes and review the results of key trials of antiplatelet therapies, both completed and ongoing, and their effects on clinical practice.
- Apply current ACC/AHA guidelines for non ST-Elevation myocardial infarction to appropriately risk-stratified patients with unstable angina and acute coronary syndrome.
- Characterize, identify, and evaluate the safety, efficacy, and side effects of therapeutic ioptions used for acute ischemic coronary syndromes including, aspirin, antiplatelet agents, direct thrombin inhibitors, UFH, LMWHs, and factor Xa inhibitors.
- Develop strategies to improve both physician adherence to ACS guidelines and patient adherence to prescribed ACS treatments.
- Identify causes of healthcare disparities in the management of acute coronary syndromes, and provide practical strategies to improve outcomes in Black, Hispanic and Female popluations.
- Review the clinical evidence and validate the importance of achieving an LDL-C of less than 70 mg/dL in patients with acute coronary syndrome.
- Discuss the role of lipoproteins in the pathogenesis of the vulnerable plaque, understand the risk associated with low HDL in patients with acute coronary syndrome, and review ongoing trials evaluating lipoprotein changes in patients with ACS.
- Apply the use of cardiovascular genomics to predict risk for acute coronary syndrome.
Accreditation and Credit Designation
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Chicago Pritzker School of Medicine designates this educational activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The estimated time for completion of this activity is 7 hours.
Release Date: August 1, 2010.
Credit Expiration Date: July 31, 2012.
Improving Outcomes in Patients with Acute Coronary Syndrome is a complementary, online Performance Improvement (PI) CME activity that provides participants the tools to measure quality of care and to identify opportunities to improve the management of care and outcomes of patients with Acute Coronary Syndrome. Participate and earn up to 20 AMA PRA Category 1 Credits™. Use the data from this PI CME activity to complete ABIM’s Self-Directed PIM and earn ABIM Maintenance of Certification credits.
Registration is limited so apply today.
Commercial Support Disclosure
This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC and an independent educational grant from Genentech, a member of the Roche Group.
Disclaimer
The information presented in this activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgement of a physician regarding diagnosis and treatment of a specific patient’s medical condition.
Back to Cardiology
|
Up to 7 CME Credits
|
Head and Neck Cancer
Email this page
